Yulun Wang is Head of Research & Development at Teladoc Health, Inc. (TDOC). They have made 6 open-market trades across 1 company since 2020, most recently 2021-01-25.
CIK 0001055915
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TDOC | 219,507 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2021-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TDOC | SELL | 2021-01-25 | 2021-01-27 | $280.00 | $2.3M | +9.7% | -17.7% | -29.3% |
| TDOC | SELL | 2021-01-22 | 2021-01-25 | $260.00 | $2.1M | -2.5% | -10.3% | -33.0% |
| TDOC | SELL | 2021-01-20 | 2021-01-22 | $240.00 | $1.9M | +2.2% | +1.2% | -31.7% |
| TDOC | SELL | 2021-01-14 | 2021-01-19 | $226.66 | $1.8M | +12.3% | +20.5% | -21.7% |
| TDOC | SELL | 2020-12-14 | 2020-12-16 | $199.24 | $498K | +4.7% | +18.6% | +4.6% |
| TDOC | SELL | 2020-12-04 | 2020-12-07 | $201.30 | $1.2M | -1.5% | +2.2% | -11.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.